United States

MAP Pharmaceuticals, Inc. (MAPP)

Track

Stock chart
Ticker: MAPP
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
HENWOOD GERALDINE
1 sale — total 250,000 USD
Planned sale 28 Feb 2013
Value US$4,587,949.65 | Price 59.22 | Shares 27,975
Planned sale 28 Feb 2013
Value US$1,785,509.49 | Price 424.76 | Shares 2,081
Sale 26 Jan 2013
Value US$18,909.00 | Price 24.75 | Shares 764
Planned sale 23 Jan 2013
Value US$1,980,800.00 | Price 24.76 | Shares 80,000
Planned sale 23 Jan 2013
Value US$1,476,191.20 | Price 24.76 | Shares 59,620
Planned sale 23 Jan 2013
Value US$742,800.00 | Price 24.76 | Shares 30,000
Planned sale 23 Nov 2012
Value US$56,250.00 | Price 15.00 | Shares 3,750
Planned sale 23 Nov 2012
Value US$22,350.00 | Price 15.00 | Shares 1,490
Planned sale 1 Nov 2012
Value US$90,202.80 | Price 15.64 | Shares 5,767
Planned sale 2 Apr 2012
Value US$35,946.50 | Price 14.38 | Shares 2,500
Planned sale 9 Mar 2012
Value US$175,000.00 | Price 17.50 | Shares 10,000
Planned sale 9 Mar 2012
Value US$175,000.00 | Price 17.50 | Shares 10,000
Planned sale 21 Feb 2012
Value US$22,152.80 | Price 15.99 | Shares 1,385
Planned sale 21 Feb 2012
Value US$17,864.31 | Price 16.02 | Shares 1,115
Planned sale 14 Feb 2012
Value US$484,142.38 | Price 15.62 | Shares 30,999
Planned sale 6 Feb 2012
Value US$298,020.00 | Price 15.00 | Shares 19,868
Planned sale 6 Feb 2012
Value US$150,000.00 | Price 15.00 | Shares 10,000
Planned sale 19 Jan 2012
Value US$62,078.49 | Price 13.88 | Shares 4,471
Planned sale 21 Dec 2011
Value US$96,413.63 | Price 14.52 | Shares 6,638
Planned sale 20 Dec 2011
Value US$193,809.13 | Price 14.50 | Shares 13,362
Planned sale 12 Dec 2011
Value US$113,190.41 | Price 8,672.00 | Shares 13
Planned sale 12 Dec 2011
Value US$17,630.40 | Price 13.28 | Shares 1,328
Planned sale 20 Sep 2011
Value US$492,278.40 | Price 15.38 | Shares 32,000
Planned sale 1 Aug 2011
Value US$22,884.45 | Price 15.26 | Shares 1,500
Planned sale 1 Jul 2011
Value US$23,938.50 | Price 15.96 | Shares 1,500
Planned sale 1 Jun 2011
Value US$25,453.50 | Price 16.97 | Shares 1,500
Planned sale 9 May 2011
Value US$85,000.00 | Price 17.00 | Shares 5,000
Planned sale 2 May 2011
Value US$23,178.75 | Price 15.45 | Shares 1,500
Planned sale 1 Apr 2011
Value US$21,062.40 | Price 14.04 | Shares 1,500
Buy 11 Mar 2011
Value US$31,380.00 | Price 15.69 | Shares 2,000
Sale 4 Mar 2011
Value US$482,979.00 | Price 16.10 | Shares 30,000
Planned sale 1 Mar 2011
Value US$23,785.95 | Price 15.86 | Shares 1,500
Planned sale 1 Feb 2011
Value US$38,676.75 | Price 15.47 | Shares 2,500
Planned sale 3 Jan 2011
Value US$41,971.75 | Price 16.79 | Shares 2,500
Planned sale 20 Dec 2010
Value US$48,360.00 | Price 15.50 | Shares 3,120
Planned sale 15 Dec 2010
Value US$37,051.75 | Price 14.82 | Shares 2,500
Planned sale 27 Oct 2010
Value US$58,714.12 | Price 15.66 | Shares 3,750
Planned sale 27 Oct 2010
Value US$68,713.58 | Price 15.66 | Shares 4,387
Planned sale 27 Oct 2010
Value US$25,470.36 | Price 15.65 | Shares 1,627
Planned sale 27 Oct 2010
Value US$121,098.90 | Price 15.53 | Shares 7,800
Planned sale 20 Sep 2010
Value US$224,808.00 | Price 14.05 | Shares 16,000
Planned sale 1 Sep 2010
Value US$36,433.48 | Price 11.21 | Shares 3,250
Sale 5 Aug 2010
Value US$153,406.80 | Price 12.78 | Shares 12,000
Planned sale 2 Aug 2010
Value US$43,841.52 | Price 13.49 | Shares 3,250
Planned sale 21 Jul 2010
Value US$104,000.00 | Price 13.00 | Shares 8,000
Planned sale 20 Jul 2010
Value US$99,384.00 | Price 12.42 | Shares 8,000
Planned sale 1 Jul 2010
Value US$182,289.00 | Price 12.15 | Shares 15,000
Planned sale 1 Jul 2010
Value US$40,532.38 | Price 12.47 | Shares 3,250
Planned sale 3 Jun 2010
Value US$49,294.20 | Price 14.17 | Shares 3,480
Planned sale 1 Jun 2010
Value US$46,751.90 | Price 14.39 | Shares 3,250
Planned sale 1 Jun 2010
Value US$383,031.01 | Price 14.44 | Shares 26,520
Planned sale 20 May 2010
Value US$236,345.60 | Price 14.77 | Shares 16,000
Planned sale 13 May 2010
Value US$26,633.57 | Price 17.07 | Shares 1,560
Planned sale 13 May 2010
Value US$512,790.00 | Price 17.09 | Shares 30,000
Planned sale 3 May 2010
Value US$59,484.42 | Price 18.30 | Shares 3,250
Planned sale 26 Apr 2010
Value US$183,063.17 | Price 18.03 | Shares 10,155
Planned sale 14 Apr 2010
Value US$25,041.59 | Price 16.05 | Shares 1,560
Planned sale 1 Apr 2010
Value US$51,732.85 | Price 15.92 | Shares 3,250
Planned sale 24 Mar 2010
Value US$131,745.60 | Price 16.47 | Shares 8,000
Planned sale 23 Mar 2010
Value US$133,789.60 | Price 16.72 | Shares 8,000
Sale 16 Mar 2010
Value US$1,872,882.00 | Price 16.20 | Shares 115,610
Sale 15 Mar 2010
Value US$675,237.76 | Price 16.01 | Shares 42,176
Sale 12 Mar 2010
Value US$11,373.66 | Price 16.11 | Shares 706
Sale 12 Mar 2010
Value US$1,711,500.00 | Price 16.30 | Shares 105,000
Sale 11 Mar 2010
Value US$872,058.00 | Price 16.06 | Shares 54,300
Sale 11 Mar 2010
Value US$872,058.00 | Price 16.06 | Shares 54,300
Sale 10 Mar 2010
Value US$33,753.50 | Price 16.15 | Shares 2,090
Sale 10 Mar 2010
Value US$2,151,065.70 | Price 16.03 | Shares 134,190
Sale 10 Mar 2010
Value US$2,151,065.70 | Price 16.03 | Shares 134,190
Sale 10 Mar 2010
Value US$62,957.00 | Price 16.04 | Shares 3,925
Sale 9 Mar 2010
Value US$2,347,072.00 | Price 15.50 | Shares 151,424
Sale 9 Mar 2010
Value US$2,347,072.00 | Price 15.50 | Shares 151,424
Sale 9 Mar 2010
Value US$76,050.00 | Price 15.21 | Shares 5,000
Sale 9 Mar 2010
Value US$252,036.40 | Price 15.40 | Shares 16,366
Sale 9 Mar 2010
Value US$9,763.60 | Price 15.40 | Shares 634
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2013-03-04 2013-02-28 PlS Planned sale HENWOOD GERALDINE Non-Executive Director
27,975 -28.1%
59.22
US$4,587,950 		27,975 -28.1% 59.22 US$4,587,950
2013-03-04 2013-02-28 PlS Planned sale GIANAKAKOS ANASTASIOS

SVP, Chief Business Officer

Officer
2,081 -9.4%
424.76
US$1,785,509 		2,081 -9.4% 424.76 US$1,785,509
2013-01-29 2013-01-26 S Sale Borland Scott

SVP, Neurology Franchise

Officer
4,131 -47.6%
297.46
US$3,585,821 		4,131 -47.6% 297.46 US$3,585,821
2013-01-25 2013-01-23 PlS Planned sale NELSON TIMOTHY S

President and CEO

Executive Director
80,000 -70.8%
24.76
US$1,980,800 		80,000 -70.8% 24.76 US$1,980,800
2013-01-25 2013-01-23 PlS Planned sale ARMER THOMAS A

Chief Scientific Officer

Executive Director
59,620 -31.6%
24.76
US$1,476,191 		59,620 -31.6% 24.76 US$1,476,191
2013-01-25 2013-01-23 PlS Planned sale GIANAKAKOS ANASTASIOS

SVP, Chief Business Officer

Officer
30,000 -67.7%
24.76
US$742,800 		30,000 -67.7% 24.76 US$742,800
2012-11-27 2012-11-23 PlS Planned sale HENWOOD GERALDINE Non-Executive Director
3,750 -100.0%
15.00
US$56,250 		3,750 -100.0% 15.00 US$56,250
2012-11-27 2012-11-23 PlS Planned sale HENWOOD GERALDINE Non-Executive Director
1,490 -100.0%
15.00
US$22,350 		1,490 -100.0% 15.00 US$22,350
2012-11-05 2012-11-01 PlS Planned sale GIANAKAKOS ANASTASIOS

SVP, Chief Business Officer

Officer
5,767 -31.8%
15.64
US$90,203 		5,767 -31.8% 15.64 US$90,203
2012-04-04 2012-04-02 PlS Planned sale GIANAKAKOS ANASTASIOS

SVP, Chief Business Officer

Officer
2,500 -16.8%
14.38
US$35,946 		2,500 -16.8% 14.38 US$35,946
2012-03-13 2012-03-09 PlS Planned sale GIANAKAKOS ANASTASIOS

SVP, Chief Business Officer

Officer
10,000 -44.7%
17.50
US$175,000 		10,000 -44.7% 17.50 US$175,000
2012-03-13 2012-03-09 PlS Planned sale Friedman Charlene A

SVP, Gen Counsel & Sec

Officer
10,000 -88.4%
17.50
US$175,000 		10,000 -88.4% 17.50 US$175,000
2012-02-22 2012-02-21 PlS Planned sale GIANAKAKOS ANASTASIOS

SVP & Chief Business Officer

Officer
1,385 -10.1%
15.99
US$22,153 		1,385 -10.1% 15.99 US$22,153
2012-02-22 2012-02-21 PlS Planned sale GIANAKAKOS ANASTASIOS

SVP & Chief Business Officer

Officer
1,115 -8.3%
16.02
US$17,864 		1,115 -8.3% 16.02 US$17,864
2012-02-14 2012-02-14 PlS Planned sale ARMER THOMAS A

Chief Scientific Officer

Executive Director
30,999 -17.2%
15.62
US$484,142 		30,999 -17.2% 15.62 US$484,142
2012-02-07 2012-02-06 PlS Planned sale ARMER THOMAS A

Chief Scientific Officer

Executive Director
19,868 -8.7%
15.00
US$298,020 		19,868 -8.7% 15.00 US$298,020
2012-02-07 2012-02-06 PlS Planned sale GIANAKAKOS ANASTASIOS

SVP & Chief Business Officer

Officer
10,000 -44.7%
15.00
US$150,000 		10,000 -44.7% 15.00 US$150,000
2012-01-20 2012-01-19 PlS Planned sale GIANAKAKOS ANASTASIOS

SVP & Chief Business Officer

Officer
4,471 -32.4%
13.88
US$62,078 		4,471 -32.4% 13.88 US$62,078
2011-12-22 2011-12-21 PlS Planned sale NELSON TIMOTHY S

President and CEO

Executive Director
6,638 -17.5%
14.52
US$96,414 		6,638 -17.5% 14.52 US$96,414
2011-12-22 2011-12-20 PlS Planned sale NELSON TIMOTHY S

President and CEO

Executive Director
13,362 -29.9%
14.50
US$193,809 		13,362 -29.9% 14.50 US$193,809
2011-12-14 2011-12-12 PlS Planned sale GIANAKAKOS ANASTASIOS

SVP & Chief Bus Officer

Officer
13 -0.1%
8,672.00
US$113,190 		13 -0.1% 8,672.00 US$113,190
2011-12-14 2011-12-12 PlS Planned sale GIANAKAKOS ANASTASIOS

SVP & Chief Bus Officer

Officer
1,328 -12.5%
13.28
US$17,630 		1,328 -12.5% 13.28 US$17,630
2011-09-22 2011-09-20 PlS Planned sale CHAI CHRISTOPHER Y

Chief Financial Officer

Officer
32,000 -80.6%
15.38
US$492,278 		32,000 -80.6% 15.38 US$492,278
2011-08-03 2011-08-01 PlS Planned sale GIANAKAKOS ANASTASIOS

SVP, Cor & Business Dev

Officer
1,500 -13.9%
15.26
US$22,884 		1,500 -13.9% 15.26 US$22,884
2011-07-05 2011-07-01 PlS Planned sale GIANAKAKOS ANASTASIOS

SVP, Cor & Business Dev

Officer
1,500 -13.9%
15.96
US$23,938 		1,500 -13.9% 15.96 US$23,938
2011-06-03 2011-06-01 PlS Planned sale GIANAKAKOS ANASTASIOS

SVP, Cor & Business Dev

Officer
1,500 -13.9%
16.97
US$25,454 		1,500 -13.9% 16.97 US$25,454
2011-05-10 2011-05-09 PlS Planned sale GIANAKAKOS ANASTASIOS

SVP, Cor & Business Dev

Officer
5,000 -34.9%
17.00
US$85,000 		5,000 -34.9% 17.00 US$85,000
2011-05-03 2011-05-02 PlS Planned sale GIANAKAKOS ANASTASIOS

SVP, Cor & Business Dev

Officer
1,500 -13.9%
15.45
US$23,179 		1,500 -13.9% 15.45 US$23,179
2011-04-04 2011-04-01 PlS Planned sale GIANAKAKOS ANASTASIOS

SVP, Cor & Business Dev

Officer
1,500 -13.9%
14.04
US$21,062 		1,500 -13.9% 14.04 US$21,062
2011-03-15 2011-03-11 B Purchase WARD SCOTT R Non-Executive Director
2,000 +inf%
15.69
US$31,380 		2,000 +inf% 15.69 US$31,380
2011-03-08 2011-03-04 S Sale ARMER THOMAS A

Chief Scientific Officer

Executive Director
30,000 -12.4%
16.10
US$482,979 		30,000 -12.4% 16.10 US$482,979
2011-03-02 2011-03-01 PlS Planned sale GIANAKAKOS ANASTASIOS

SVP, Cor & Business Dev

Officer
1,500 -13.9%
15.86
US$23,786 		1,500 -13.9% 15.86 US$23,786
2011-02-03 2011-02-01 PlS Planned sale GIANAKAKOS ANASTASIOS

SVP, Cor & Business Dev

Officer
2,500 -21.2%
15.47
US$38,677 		2,500 -21.2% 15.47 US$38,677
2011-01-04 2011-01-03 PlS Planned sale GIANAKAKOS ANASTASIOS

SVP, Cor & Business Dev

Officer
2,500 -28.1%
16.79
US$41,972 		2,500 -28.1% 16.79 US$41,972
2010-12-21 2010-12-20 PlS Planned sale Friedman Charlene A

VP President, Gen Counsel &Sec

Officer
3,120 -100.0%
15.50
US$48,360 		3,120 -100.0% 15.50 US$48,360
2010-12-17 2010-12-15 PlS Planned sale GIANAKAKOS ANASTASIOS

SVP, Cor & Business Dev

Officer
2,500 -28.1%
14.82
US$37,052 		2,500 -28.1% 14.82 US$37,052
2010-10-29 2010-10-27 PlS Planned sale HENWOOD GERALDINE Non-Executive Director
3,750 -100.0%
15.66
US$58,714 		3,750 -100.0% 15.66 US$58,714
2010-10-29 2010-10-27 PlS Planned sale HENWOOD GERALDINE Non-Executive Director
4,387 -100.0%
15.66
US$68,714 		4,387 -100.0% 15.66 US$68,714
2010-10-29 2010-10-27 PlS Planned sale HENWOOD GERALDINE Non-Executive Director
1,627 -100.0%
15.65
US$25,470 		1,627 -100.0% 15.65 US$25,470
2010-10-29 2010-10-27 PlS Planned sale Friedman Charlene A

VP President, Gen Counsel &Sec

Officer
7,800 -100.0%
15.53
US$121,099 		7,800 -100.0% 15.53 US$121,099
2010-09-22 2010-09-20 PlS Planned sale CHAI CHRISTOPHER Y

Chief Financial Officer

Officer
16,000 -70.5%
14.05
US$224,808 		16,000 -70.5% 14.05 US$224,808
2010-09-03 2010-09-01 PlS Planned sale GIANAKAKOS ANASTASIOS

SVP, Cor & Business Dev

Officer
3,250 -33.7%
11.21
US$36,433 		3,250 -33.7% 11.21 US$36,433
2010-08-06 2010-08-05 S Sale HENWOOD GERALDINE Non-Executive Director
12,000 -100.0%
12.78
US$153,407 		12,000 -100.0% 12.78 US$153,407
2010-08-02 2010-08-02 PlS Planned sale GIANAKAKOS ANASTASIOS

SVP, Cor & Business Dev

Officer
3,250 -33.7%
13.49
US$43,842 		3,250 -33.7% 13.49 US$43,842
2010-07-22 2010-07-21 PlS Planned sale CHAI CHRISTOPHER Y

Chief Financial Officer

Officer
8,000 -54.4%
13.00
US$104,000 		8,000 -54.4% 13.00 US$104,000
2010-07-22 2010-07-20 PlS Planned sale CHAI CHRISTOPHER Y

Chief Financial Officer

Officer
8,000 -54.4%
12.42
US$99,384 		8,000 -54.4% 12.42 US$99,384
2010-07-02 2010-07-01 PlS Planned sale NELSON TIMOTHY S

President and CEO

Executive Director
15,000 -38.5%
12.15
US$182,289 		15,000 -38.5% 12.15 US$182,289
2010-07-02 2010-07-01 PlS Planned sale GIANAKAKOS ANASTASIOS

SVP, Cor & Business Dev

Officer
3,250 -33.7%
12.47
US$40,532 		3,250 -33.7% 12.47 US$40,532
2010-06-03 2010-06-03 PlS Planned sale NELSON TIMOTHY S

President and CEO

Executive Director
3,480 -12.7%
14.17
US$49,294 		3,480 -12.7% 14.17 US$49,294
2010-06-03 2010-06-01 PlS Planned sale GIANAKAKOS ANASTASIOS

SVP, Cor & Business Dev

Officer
3,250 -33.7%
14.39
US$46,752 		3,250 -33.7% 14.39 US$46,752
2010-06-03 2010-06-01 PlS Planned sale NELSON TIMOTHY S

President and CEO

Executive Director
26,520 -52.5%
14.44
US$383,031 		26,520 -52.5% 14.44 US$383,031
2010-05-21 2010-05-20 PlS Planned sale CHAI CHRISTOPHER Y

Chief Financial Officer

Officer
16,000 -70.5%
14.77
US$236,346 		16,000 -70.5% 14.77 US$236,346
2010-05-14 2010-05-13 PlS Planned sale Friedman Charlene A

VP President, Gen Counsel &Sec

Officer
1,560 -100.0%
17.07
US$26,634 		1,560 -100.0% 17.07 US$26,634
2010-05-14 2010-05-13 PlS Planned sale NELSON TIMOTHY S

President and CEO

Executive Director
30,000 -55.6%
17.09
US$512,790 		30,000 -55.6% 17.09 US$512,790
2010-05-05 2010-05-03 PlS Planned sale GIANAKAKOS ANASTASIOS

SVP, Cor & Business Dev

Officer
3,250 -33.7%
18.30
US$59,484 		3,250 -33.7% 18.30 US$59,484
2010-04-28 2010-04-26 PlS Planned sale Friedman Charlene A

VP President, Gen Counsel &Sec

Officer
10,155 -100.0%
18.03
US$183,063 		10,155 -100.0% 18.03 US$183,063
2010-04-15 2010-04-14 PlS Planned sale Friedman Charlene A

VP President, Gen Counsel &Sec

Officer
1,560 -100.0%
16.05
US$25,042 		1,560 -100.0% 16.05 US$25,042
2010-04-05 2010-04-01 PlS Planned sale GIANAKAKOS ANASTASIOS

SVP, Cor & Business Dev

Officer
3,250 -33.7%
15.92
US$51,733 		3,250 -33.7% 15.92 US$51,733
2010-03-25 2010-03-24 PlS Planned sale CHAI CHRISTOPHER Y

Chief Financial Officer

Officer
8,000 -54.4%
16.47
US$131,746 		8,000 -54.4% 16.47 US$131,746
2010-03-25 2010-03-23 PlS Planned sale CHAI CHRISTOPHER Y

Chief Financial Officer

Officer
8,000 -54.4%
16.72
US$133,790 		8,000 -54.4% 16.72 US$133,790
2010-03-16 2010-03-16 S Sale GOLDFISCHER CARL Non-Executive Director
115,610 -6.2%
16.20
US$1,872,882 		115,610 -6.2% 16.20 US$1,872,882
2010-03-16 2010-03-15 S Sale GOLDFISCHER CARL Non-Executive Director
42,176 -2.2%
16.01
US$675,238 		42,176 -2.2% 16.01 US$675,238
2010-03-16 2010-03-12 S Sale SOROS FUND MANAGEMENT LLC Large shareholder
706 -0.0%
16.11
US$11,374 		706 -0.0% 16.11 US$11,374
2010-03-16 2010-03-12 S Sale GOLDFISCHER CARL Non-Executive Director
105,000 -5.2%
16.30
US$1,711,500 		105,000 -5.2% 16.30 US$1,711,500
2010-03-11 2010-03-11 S Sale GOLDFISCHER CARL Non-Executive Director
54,300 -2.6%
16.06
US$872,058 		54,300 -2.6% 16.06 US$872,058
2010-03-11 2010-03-11 S Sale Bay City Capital Fund IV, L.P. Large shareholder
54,300 -2.6%
16.06
US$872,058 		54,300 -2.6% 16.06 US$872,058
2010-03-12 2010-03-10 S Sale ELMS STEVE Non-Executive Director
2,090 -100.0%
16.15
US$33,754 		2,090 -100.0% 16.15 US$33,754
2010-03-11 2010-03-10 S Sale GOLDFISCHER CARL Non-Executive Director
134,190 -6.1%
16.03
US$2,151,066 		134,190 -6.1% 16.03 US$2,151,066
2010-03-11 2010-03-10 S Sale Bay City Capital Fund IV, L.P. Large shareholder
134,190 -6.1%
16.03
US$2,151,066 		134,190 -6.1% 16.03 US$2,151,066
2010-03-10 2010-03-10 S Sale PERSEUSPUR LLC Large shareholder
3,925 -0.1%
16.04
US$62,957 		3,925 -0.1% 16.04 US$62,957
2010-03-11 2010-03-09 S Sale GOLDFISCHER CARL Non-Executive Director
151,424 -6.5%
15.50
US$2,347,072 		151,424 -6.5% 15.50 US$2,347,072
2010-03-11 2010-03-09 S Sale Bay City Capital Fund IV, L.P. Large shareholder
151,424 -6.5%
15.50
US$2,347,072 		151,424 -6.5% 15.50 US$2,347,072
2010-03-10 2010-03-09 S Sale PERSEUSPUR LLC Large shareholder
5,000 -0.2%
15.21
US$76,050 		5,000 -0.2% 15.21 US$76,050
2010-03-10 2010-03-09 S Sale SOROS FUND MANAGEMENT LLC Large shareholder
16,366 -0.6%
15.40
US$252,036 		16,366 -0.6% 15.40 US$252,036
2010-03-10 2010-03-09 S Sale SOROS FUND MANAGEMENT LLC Large shareholder
634 -0.0%
15.40
US$9,764 		634 -0.0% 15.40 US$9,764
Explore more

More insider trading research around MAP Pharmaceuticals, Inc.

More insider trades in United States
Insider trading in North America